Physician profile
James Alexander
NPI 1649366956
$1,710.23
in general payments reported to CMS, 2019-2025
19 companies · $420 in 2025
The $420 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.46 · 2020: $33.83 · 2021: $139 · 2022: $196 · 2023: $355 · 2024: $551 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,326.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $979.75 | 2021-2025 | Collagenase Santyl, Grafix Pl, Regranex |
| Organogenesis INC. | $110.14 | 2022-2025 | Apligraf |
| Solventum Corporation | $104.08 | 2024-2025 | Activ.A.C., Promogran Prisma, 3m Cavilon |
| Bsn Medical INC | $68.66 | 2024 | |
| Lifenet Health | $62.01 | 2025 | Theragenesis Wound Matrix |
| Avita Medical Americas, LLC | $54.53 | 2025 | Permeaderm, Cohealyx, Recell |
| Amgen INC. | $49.84 | 2023-2024 | Repatha |
| Polarityte, INC. | $33.83 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.00 | 2024 | Jardiance |
| Next Science LLC | $31.80 | 2023-2024 | Xperience, Blastx, Surgx |
| Integra Lifesciences Corporation | $31.63 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Daiichi Sankyo INC. | $25.79 | 2022 | |
| Paratek Pharmaceuticals, INC. | $22.09 | 2025 | Nuzyra |
| Hartmann USA, INC. | $21.52 | 2025 | Zetuvit Plus 10x10 P10 |
| Convatec INC. | $21.06 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $19.86 | 2024 | |
| Urgo Medical North America, LLC | $15.90 | 2024 | Urgok2 |
| Chiesi USA, INC. | $15.46 | 2019 | |
| Cashflow Solutions, LLC | $9.28 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.